Patents Assigned to EVOFEM, INC.
  • Patent number: 11992472
    Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: May 28, 2024
    Assignee: Evofem, Inc.
    Inventor: Wendell Guthrie
  • Patent number: 11439610
    Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to synergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: September 13, 2022
    Assignee: Evofem, Inc.
    Inventor: Wendell Guthrie
  • Patent number: 11419835
    Abstract: Described herein are methods of reducing the risk of recurrence of bacterial vaginosis by intravaginal administration of compositions comprising L-lactic acid, polymer thickener, and preservative.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: August 23, 2022
    Assignee: Evofem, Inc.
    Inventor: David R. Friend
  • Patent number: 11337989
    Abstract: The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating viruses and other microbes and (2) blocking the host response that viruses trigger to invade host cells. Such compositions can also be part of an acid buffering contraceptive.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: May 24, 2022
    Assignee: Evofem, Inc.
    Inventors: Wendell Guthrie, Gary S. Hahn
  • Patent number: 10568855
    Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: February 25, 2020
    Assignee: Evofem, Inc.
    Inventor: Wendell Guthrie
  • Patent number: 9566232
    Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: February 14, 2017
    Assignee: EVOFEM, INC.
    Inventor: Wendell Guthrie
  • Publication number: 20150202216
    Abstract: The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
    Type: Application
    Filed: March 15, 2013
    Publication date: July 23, 2015
    Applicant: EVOFEM, INC.
    Inventor: Wendell Guthrie